Fluocinolone acetonide
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration | Topical |
ATC code | C05AA10 (WHO) D07AC04 (WHO) S01BA15 (WHO) S02BA08 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic, CYP3A4-mediated |
Biological half-life | 1.3 to 1.7 hours |
Identifiers | |
| |
CAS Number | 67-73-2 |
PubChem (CID) | 6215 |
IUPHAR/BPS | 7077 |
DrugBank | DB00591 |
ChemSpider | 5980 |
UNII | 0CD5FD6S2M |
KEGG | D01825 |
ChEBI | CHEBI:31623 |
ChEMBL | CHEMBL989 |
ECHA InfoCard | 100.000.607 |
Chemical and physical data | |
Formula | C24H30F2O6 |
Molar mass | 452.488 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Fluocinolone acetonide is a corticosteroid primarily used in dermatology to reduce skin inflammation and relieve itching. It is a synthetic hydrocortisone derivative. The fluorine substitution at position 9 in the steroid nucleus greatly enhances its activity. It was first synthesized in 1959 in the Research Department of Syntex Laboratories S.A. Mexico City.[1] Preparations containing it were first marketed under the name Synalar. A typical dosage strength used in dermatology is 0.01–0.025%. One such cream is sold under the brand name Flucort-N and includes the antibiotic neomycin.
Fluocinolone acetonide was also found to strongly potentiate TGF-β-associated chondrogenesis of bone marrow mesenchymal stem/progenitor cells, by increasing the levels of collagen type II by more than 100 fold compared to the widely used dexamethasone.[2]
Fluocinolone acetonide intravitreal implants have been used to treat non-infectious uveitis. A systematic review could not determine whether fluocinolone acetonide implants are superior to standard of care treatment for uveitis.[3]
Flucinolone is a group V (0.025%) or group VI (0.01%) corticosteroid under US classification.
See also
References
- ↑ J S Mills, A. Bowers, Carl Djerassi and H.J. Ringold, Steroids CXXXVII. Synthesis of a New Class of Potent Cortical Hormones. 6α,9α-Difluoro-16α-Hydroxyprednisolone and its Acetonide, Journal of the American Chemical Society, 80, 3399-3404 (1960)
- ↑ Hara ES, Ono M, Pham HT, Sonoyama W, Kubota S, Takigawa M, Matsumoto T, Young MF, Olsen BR, Kuboki T. Fluocinolone Acetonide is a Potent Synergistic Factor of TGF-β3-Associated Chondrogenesis of Bone Marrow-Derived Mesenchymal Stem Cells for Articular Surface Regeneration. J Bone Miner Res. 2015. http://onlinelibrary.wiley.com/doi/10.1002/jbmr.2502/abstract
- ↑ Brady CJ, Villanti AC, Law HA, Rahimy E, Reddy R, Sieving PC, Garg SJ, Tang J (2016). "Corticosteroid implants for chronic non-infectious uveitis". Cochrane Database Syst Rev. 2: CD010469. doi:10.1002/14651858.CD010469.pub2. PMID 26866343.